Progress and Prospects: Prospects of repeated pulmonary administration of viral vectors

Gene Therapy

Volumn 16, Issue 9, 2009, Pages 1059-1065

  Sinn, P L ^a   Burnight, E R ^a   McCray Jr , P B ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; ALPHA 1 ANTITRYPSIN; BETA GALACTOSIDASE; CAPSID PROTEIN; CARBAMIC ACID DERIVATIVE; CARBAMOYL CHOLESTEROL; CD40 LIGAND; COMPLEMENTARY DNA; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; DEXAMETHASONE; DIOLEOYLPHOSPHATIDYLETHANOLAMINE; IMMUNOLOGICAL ADJUVANT; LENTIVIRUS VECTOR; LIPID; MACROGOL; NEUTRALIZING ANTIBODY; PARVOVIRUS VECTOR; SPERMINE; UNCLASSIFIED DRUG; VIRUS VECTOR;

ADAPTIVE IMMUNITY; ANTIBODY BLOOD LEVEL; ANTIBODY RESPONSE; ANTIBODY TITER; ANTIGEN EXPRESSION; ANTIINFLAMMATORY ACTIVITY; CELLULAR IMMUNITY; CYTOTOXIC T LYMPHOCYTE; GENE TRANSFER; HUMAN; HUMORAL IMMUNITY; IMMUNOGENICITY; IMMUNOSUPPRESSIVE TREATMENT; INNATE IMMUNITY; LUNG CAVITY; NONHUMAN; NOSE CAVITY; PRIORITY JOURNAL; REPEAT PROCEDURE; REVIEW; SEROTYPE; VIRAL GENE DELIVERY SYSTEM; VIRUS LIKE AGENT;

ADAPTIVE IMMUNITY; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HUMANS; IMMUNITY, INNATE; LUNG DISEASES; VIRUSES;

EID: 70249127531     PISSN: 09697128     EISSN: 14765462     Source Type: Journal    
DOI: 10.1038/gt.2009.87     Document Type: Review

References (20)

1. Kawai T, Akira S. Toll-like receptor and RIG-I-like receptor signaling. Ann N Y Acad Sci 2008; 1143: 1-20.
2. Sinn PL, Arias AC, Brogden KA, McCray Jr PB. Lentivirus vector can be readministered to nasal epithelia without blocking immune responses. J Virol 2008; 82: 10684-10692.
3. Halbert CL, Miller AD, McNamara S, Emerson J, Gibson RL, Ramsey B et al. Prevalence of neutralizing antibodies against adeno-associated virus (AAV) types 2, 5, and 6 in cystic fibrosis and normal populations: Implications for gene therapy using AAV vectors. Hum Gene Ther 2006; 17: 440-447.
4. Bangari DS, Mittal SK. Current strategies and future directions for eluding adenoviral vector immunity. Curr Gene Ther 2006; 6: 215-226.
5. Limberis MP, Wilson JM. Adeno-associated virus serotype 9 vectors transduce murine alveolar and nasal epithelia and can be readministered. Proc Natl Acad Sci USA 2006; 103: 12993-12998.
6. Kwon I, Schaffer DV. Designer gene delivery vectors: Molecular engineering and evolution of adeno-associated viral vectors for enhanced gene transfer. Pharm Res 2008; 25: 489-499.
7. Eto Y, Yoshioka Y, Mukai Y, Okada N, Nakagawa S. Development of PEGylated adenovirus vector with targeting ligand. Int J Pharm 2008; 354: 3-8.
8. Price AR, Limberis MP, Wilson JM, Diamond SL. Pulmonary delivery of adenovirus vector formulated with dexamethasonespermine facilitates homologous vector re-administration. Gene Therapy 2007; 14: 1594-1604.
9. Brunetti-Pierri N, Ng P. Progress towards the clinical application of helper-dependent adenoviral vectors for liver and lung gene therapy. Curr Opin Mol Ther 2006; 8: 446-454.
10. Brunetti-Pierri N, Ng T, Iannitti DA, Palmer DJ, Beaudet AL, Finegold MJ et al. Improved hepatic transduction, reduced systemic vector dissemination, and long-term transgene expression by delivering helper-dependent adenoviral vectors into the surgically isolated liver of nonhuman primates. Hum Gene Ther 2006; 17: 391-404.
11. Koehler DR, Martin B, Corey M, Palmer D, Ng P, Tanswell AK et al. Readministration of helper-dependent adenovirus to mouse lung. Gene Therapy 2006; 13: 773-780.
12. Vandenberghe LH, Wang L, Somanathan S, Zhi Y, Figueredo J, Calcedo R et al. Heparin binding directs activation of T cells against adeno-associated virus serotype 2 capsid. Nat Med 2006; 12: 967-971.
13. Sumner-Jones SG, Gill DR, Hyde SC. Lack of repeat transduction by recombinant adeno-associated virus type 5/5 vectors in the mouse airway. J Virol 2007; 81: 12360-12367.
14. De BP, Heguy A, Hackett NR, Ferris B, Leopold PL, Lee J et al. High levels of persistent expression of alpha1-antitrypsin mediated by the nonhuman primate serotype rh.10 adeno-associated virus despite preexisting immunity to common human adeno-associated viruses. Mol Ther 2006; 13: 67-76.
15. Levine BL, Humeau LM, Boyer J, MacGregor RR, Rebello T, Lu X et al Gene transfer in humans using a conditionally replicating lentiviral vector. Proc Natl Acad Sci USA 2006; 103: 17372-17377.
16. Buckley SM, Howe SJ, Sheard V, Ward NJ, Coutelle C, Thrasher AJ et al Lentiviral transduction of the murine lung provides efficient pseudotype and developmental stage-dependent cell-specific transgene expression. Gene Therapy 2008; 15: 1167-1175.
17. Brown BD, Sitia G, Annoni A, Hauben E, Sergi LS, Zingale A et al. In vivo administration of lentiviral vectors triggers a type I interferon response that restricts hepatocyte gene transfer and promotes vector clearance. Blood 2007; 109: 2797-2805.
18. Excoffon KJ, Koerber JT, Dickey DD, Murtha M, Keshavjee S, Kaspar BK et al. Directed evolution of adeno-associated virus to an infectious respiratory virus. Proc Natl Acad Sci USA 2009; 106: 3865-3870.
19. Brown BD, Cantore A, Annoni A, Sergi LS, Lombardo A, Della Valle P et al. A microRNA-regulated lentiviral vector mediates stable correction of hemophilia B mice. Blood 2007; 110: 4144-4152.
20. Kelly EJ, Russell SJ. MicroRNAs and the regulation of vector tropism. Mol Ther 2009; 17: 409-416.